← Astrana Health, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $44.0m | $357.7m | $519.9m | $560.6m | $687.2m | $773.9m | $1.1b | $1.4b | $2.0b | $3.2b | |
| Cost of Revenue | $34.4m | $296.2m | $361.1m | $467.8m | $539.2m | $596.1m | $944.7m | $1.2b | $1.8b | $2.8b | |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | $34.4m | $296.2m | $361.1m | $467.8m | $539.2m | $596.1m | $944.7m | $1.2b | $1.8b | $2.8b | |
| Gross Profit (Calculated) (derived) | $9.7m | $61.6m | $158.8m | $92.8m | $148.0m | $177.8m | $199.5m | $215.0m | $271.4m | $341.5m | |
| Operating Expenses | $51.3m | $322.6m | $431.5m | $528.2m | — | — | — | — | — | — | |
| Operating Income (Loss) | ($7.3m) | $35.1m | $88.4m | $32.4m | $80.5m | $98.2m | $104.3m | $84.6m | $89.3m | $78.5m | |
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | — | — | — | $16.3m | $16.0m | $15.4m | $13.7m | $12.7m | $25.6m | $40.7m | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | — | — | — | $2.3m | ($4.1m) | ($146k) | — | |
| Gain (Loss) on Investments | — | $13.7m | $0 | $0 | $99.8m | ($10.7m) | ($21.3m) | ($4.6m) | $731k | ($68k) | |
| Goodwill, Impairment Loss | $546k | — | $3.8m | $3.8m | $0 | $0 | $0 | $0 | $0 | $0 | |
| Income (Loss) from Equity Method Investments | — | ($1.1m) | ($8.1m) | ($6.9m) | $3.7m | ($4.3m) | $5.6m | $5.6m | $4.5m | $1.7m | |
| Investment Income, Interest | — | $1.0m | $1.3m | $2.0m | $2.8m | $1.6m | $2.0m | $14.2m | $14.5m | $12.2m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $1.2m | $288k | $49.4m | $3.6m | $84.5m | $77.7m | $86.6m | $89.8m | $80.8m | $39.6m | |
| Gain (Loss) on Derivative Instruments, Net, Pretax | ($409k) | ($45k) | $0 | $0 | — | — | — | — | — | — | |
| Net Income (Loss) Attributable to Parent | ($9.3m) | $25.8m | $10.8m | $14.1m | $37.9m | $73.9m | $45.2m | $60.7m | $43.1m | $22.5m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $1.2m | $20.0m | $49.4m | $3.6m | $84.5m | ($24.6m) | $570k | ($2.9m) | $6.8m | $1.6m | |
| Earnings Per Share, Basic | $0.46 | $1.01 | $0.33 | $0.41 | $1.04 | $1.69 | $1.00 | $1.30 | $0.91 | $0.46 | |
| Earnings Per Share, Diluted | $0.41 | $0.90 | $0.29 | $0.39 | $1.01 | $1.63 | $0.99 | $1.29 | $0.90 | $0.46 | |
| Weighted Average Number of Shares Outstanding, Basic | — | 25.5m | 32.9m | 34.7m | 36.5m | 43.8m | 45.0m | 46.6m | 47.6m | 49.1m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | 28.7m | 37.9m | 36.4m | 37.4m | 45.4m | 45.6m | 46.9m | 48.0m | 49.4m | |
| Other Nonoperating Income (Expense) | $239k | $168k | $1.6m | $3.0m | $1.1m | ($3.8m) | $3.9m | $6.1m | $4.9m | ($2.8m) | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $33.1m | $49.9m | |
| Cost, Depreciation and Amortization | — | — | — | — | — | — | $17.5m | $17.7m | $27.9m | $45.7m | |
| Costs and Expenses | — | — | — | — | $606.7m | $675.7m | $1.0b | $1.3b | $1.9b | $3.1b | |
| Current Income Tax Expense (Benefit) | $57k | $24.6m | $30.7m | $15.0m | $62.7m | $34.4m | $55.2m | $44.4m | $35.1m | $19.8m | |
| General and Administrative Expense | $17.0m | $26.4m | $43.4m | $41.5m | $49.1m | $62.1m | $77.7m | $112.6m | $154.1m | $217.3m | |
| Interest Expense | $542k | $80k | $561k | $4.7m | $9.5m | $5.4m | $7.9m | $16.1m | $33.1m | $49.9m | |
| Interest Expense, Debt | $183k | — | — | — | — | — | — | — | — | — | |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | — | — | — | — | $306.6m | $348.3m | $651.8m | $852.9m | $1.3b | $1.9b | |
| Nonoperating Income (Expense) | ($978k) | $14.6m | ($5.8m) | ($6.6m) | $97.9m | ($20.4m) | ($17.6m) | $5.2m | ($8.5m) | ($38.9m) | |
| Income Tax Expense (Benefit) | ($71k) | $3.9m | $22.4m | $8.2m | $56.1m | $28.5m | $40.9m | $32.0m | $30.9m | $15.5m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.